Tacrolimus: Physicochemical stability challenges, analytical methods, and new formulations

被引:0
|
作者
Sajjadi, Sara [1 ,4 ]
Shayanfar, Ali [2 ]
Kiafar, Farhad [3 ]
Siahi-Shadbad, Mohammadreza [4 ]
机构
[1] Tabriz Univ Med Sci, Student Res Comm, Tabriz, Iran
[2] Tabriz Univ Med Sci, Pharmaceut Anal Res Ctr, Tabriz, Iran
[3] Tabriz Univ Med Sci, Fac Pharm, Dept Pharmaceut, Tabriz, Iran
[4] Tabriz Univ Med Sci, Fac Pharm, Pharmaceut & Food Control Dept, Tabriz, Iran
关键词
Tacrolimus; Drug stability; Pharmaceutical formulation; Solubility; SOLID LIPID NANOPARTICLES; IN-SITU GEL; DRUG-DELIVERY; NANOCAPSULES; CYCLOSPORINE; NANOEMULSION; DEGRADATION; PERFORMANCE;
D O I
10.1016/j.ijpx.2024.100285
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tacrolimus, a potent immunosuppressant, is widely used in several formulations to treat organ rejection in transplant patients. However, its physicochemical stability poses significant challenges, including thermal instability, photostability issues, low solubility, and drug-excipient incompatibility. This review article focuses on the details of these challenges and discusses the analytical methods employed to study tacrolimus stability, such as thermal, spectroscopic, and chromatographic methods in different formulations. New formulations to enhance tacrolimus stability are explored, including lipid-based nanocarriers, polymers, and thin film freezing. Researchers and formulators can optimize tacrolimus formulations to improve efficacy and patient outcomes by understanding and addressing these stability challenges.
引用
收藏
页数:19
相关论文
共 50 条